-
EP1978968
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1978968
| EP1978968 - CATIONIC STEROID ANTIMICROBIAL COMPOSITIONS FOR TREATING OR PREVENTING HIV INFECTIONS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 22.03.2019 Database last updated on 15.07.2024 | |
| Former | Examination is in progress Status updated on 25.09.2018 | Most recent event Tooltip | 22.03.2019 | Application deemed to be withdrawn | published on 24.04.2019 [2019/17] | Applicant(s) | For all designated states Brigham Young University 3760 HBLL Provo, UT 84602-6844 / US | For all designated states Vanderbilt University 305 Kirkland Hall 2201 West End Avenue Nashville, TN 37240 / US | [N/P] |
| Former [2008/42] | For all designated states Brigham Young University 3760 HBLL Provo, UT 84602-6844 / US | ||
| For all designated states Vanderbilt University 2201 West End Avenue Nashville, TN 37235 / US | Inventor(s) | 01 /
SAVAGE, Paul, B. 1075 East Maple Street Mapleton, UT 84664 / US | 02 /
UNUTMAZ, Derya 1900 Richard Jones Road, Apt. V4 Nashville, TN 37215 / US | [2008/42] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [N/P] |
| Former [2008/42] | Vossius & Partner Siebertstrasse 4 81675 München / DE | Application number, filing date | 07762971.5 | 31.01.2007 | [2008/42] | WO2007US02794 | Priority number, date | US20060763999P | 01.02.2006 Original published format: US 763999 P | [2008/42] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2007089907 | Date: | 09.08.2007 | Language: | EN | [2007/32] | Type: | A2 Application without search report | No.: | EP1978968 | Date: | 15.10.2008 | Language: | EN | The application published by WIPO in one of the EPO official languages on 09.08.2007 takes the place of the publication of the European patent application. | [2008/42] | Search report(s) | International search report - published on: | EP | 01.11.2007 | Classification | IPC: | A61K31/56, A61K31/568, A61K31/57, A61K31/575, A61K45/06, A61P31/18, G01N33/15 | [2008/42] | CPC: |
A61K31/56 (EP,US);
A61K31/568 (EP,US);
A61K31/57 (EP,US);
A61K31/575 (EP,US);
A61K45/06 (EP,US);
A61P31/18 (EP);
Y02A50/30 (EP,US)
(-)
| C-Set: |
A61K31/568, A61K2300/00 (US,EP);
A61K31/56, A61K2300/00 (EP,US);
A61K31/575, A61K2300/00 (US,EP);
A61K31/57, A61K2300/00 (US,EP) | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/42] | Title | German: | KATIONISCHE, STEROIDE, ANTIMIKROBIELLE ZUSAMMENSETZUNGEN ZUR BEHANDLUNG ODER PRÄVENTION VON HIV-INFEKTIONEN | [2008/42] | English: | CATIONIC STEROID ANTIMICROBIAL COMPOSITIONS FOR TREATING OR PREVENTING HIV INFECTIONS | [2008/42] | French: | COMPOSITIONS ANTIMICROBIENNES STÉROÏDES CATIONIQUES ET MÉTHODES D'UTILISATION | [2008/42] | Entry into regional phase | 30.07.2008 | National basic fee paid | 30.07.2008 | Designation fee(s) paid | 30.07.2008 | Examination fee paid | Examination procedure | 30.07.2008 | Amendment by applicant (claims and/or description) | 30.07.2008 | Examination requested [2008/42] | 05.01.2012 | Despatch of a communication from the examining division (Time limit: M06) | 13.07.2012 | Reply to a communication from the examining division | 16.10.2015 | Despatch of a communication from the examining division (Time limit: M04) | 24.02.2016 | Reply to a communication from the examining division | 13.09.2018 | Despatch of a communication from the examining division (Time limit: M02) | 24.11.2018 | Application deemed to be withdrawn, date of legal effect [2019/17] | 20.12.2018 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2019/17] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 05.01.2012 | Fees paid | Renewal fee | 30.03.2009 | Renewal fee patent year 03 | 26.01.2010 | Renewal fee patent year 04 | 25.01.2011 | Renewal fee patent year 05 | 25.01.2012 | Renewal fee patent year 06 | 25.01.2013 | Renewal fee patent year 07 | 27.01.2014 | Renewal fee patent year 08 | 27.01.2015 | Renewal fee patent year 09 | 27.01.2016 | Renewal fee patent year 10 | 27.01.2017 | Renewal fee patent year 11 | 29.01.2018 | Renewal fee patent year 12 | Penalty fee | Additional fee for renewal fee | 31.01.2009 | 03 M06 Fee paid on 30.03.2009 | 31.01.2019 | 13 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO9608270 (MAGAININ PHARMA [US]) [X] 1-66 * page 4, paragraph 1 - paragraph 2 * * page 6, paragraph 3 * * page 28, paragraph 1 - page 29, paragraph 2 * * page 40, paragraph 1 * * page 41, chart ** claims 14,18 *; | [X]US5763430 (ZASLOFF MICHAEL [US]) [X] 1-66 * column 4, line 1 - line 14 * * column 4, line 61 - line 65 * * column 81, line 17 - line 48 * * claims *; | [X]US6143738 (ZASLOFF MICHAEL [US]) [X] 1-66 * column 2, line 20 - line 27 * * column 2, line 66 - column 3, line 19 * * column 5, line 4 - line 6 * * example 1 * * column 13, line 39 - column 14, line 48 * * column 15, line 27 - line 34 * * figures 1,4,5,8,9 *; | [DXA]US6767904 (SAVAGE PAUL B [US], et al) [DX] 59,60 * the whole document * [A] 1-58,61-66 |